Company Overview of World Health Organization
Avenue Appia 20
Key Executives for World Health Organization
Member of Commission on Social Determinants of Health
WHO Eastern Mediterranean Region Director
Director of The Department of Reproductive Health & Research and Director of Special Programme of Research
Compensation as of Fiscal Year 2013.
World Health Organization Key Developments
World Health Organization Presents at FT Global Pharmaceutical and Biotechnology Conference, Dec-03-2013 04:55 PM
Nov 30 13
World Health Organization Presents at FT Global Pharmaceutical and Biotechnology Conference, Dec-03-2013 04:55 PM. Venue: The InterContinental Park Lane, One Hamilton Place, Park Lane, London W1J 7QY, United Kingdom. Speakers: Joan Dzenowagis, Senior Scientist-eHealth.
World Health Organization Presents at Bloomberg's Longevity Economy Conference, Oct-10-2013 09:10 AM
Oct 9 13
World Health Organization Presents at Bloomberg's Longevity Economy Conference, Oct-10-2013 09:10 AM. Venue: Crosby Street Hotel, New York, New York, United States. Speakers: John Beard, MBBS PhD, Director, Department of Ageing and Life Course.
World Health Organization and Becton, Dickinson and Company Announce New Commitment to Address Maternal and Newborn Mortality
Sep 27 13
Becton, Dickinson and Company and the World Health Organization together with Saving Lives at Birth: A Grand Challenge for Development partners, announced a commitment to develop and launch the Odon Device, an innovative new obstetrical instrument for assisting the delivery of newborns during circumstances of troublesome labor. Obstructed or prolonged labors are common causes of maternal and child mortality in developing countries. Ten million women per year experience serious pregnancy-related medical complications such as bleeding, infection and trauma, and 260,000 maternal deaths occurred in 2012. 99% of these mortalities occur in developing countries. Approximately 3 million newborn babies die each year, and an additional 2.6 million are stillborn, in part due to complications from obstructed labor during childbirth. The Odon Device is designed to gently deliver newborns through the birth canal during complicated second-stage labor. Devices presently utilized for this purpose, such as forceps and vacuum assist, may cause damage to mothers and newborns, especially if applied by inexperienced birthing attendants. C-sections are performed extensively to address prolonged labor in high income regions such as the U.S. and Western Europe, but are far less accessible in developing countries where the majority of maternal and newborn mortalities occur.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|